PiB-, florbetapir-PET yield same results for Alzheimer's diagnosis

01/9/2013 | HealthImaging.com

PET imaging of beta-amyloid levels using Pittsburgh compound B or florbetapir yielded consistent results, according to a study in the Journal of Nuclear Medicine. The two methods gave concordant beta-amyloid positive and negative status and comparable cortical retention ratios, the study found. "These analyses are an initial step in addressing the need for standardization of AB methodologies," researchers said.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA
Assistant General Counsel, Regulatorya
Cardinal Health
Waukegan, IL
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA